Status:
UNKNOWN
ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Advance Directives
Oncology
Eligibility:
All Genders
18+ years
Brief Summary
The law about advance directives is evolving but, in France, few people write it. Te main endpoint of this research is to estimate the proportion of patients who have written their advance directives...
Eligibility Criteria
Inclusion
- \> 18 ya
- With one of the diagnoses below:
- Melanoma
- Skin lymphoma
- Meckel Carcinoma
- localy advanced or metastatic Basal cell carcinoma or squamous cell carcinoma
Exclusion
- Patients not in possession of all of its cognitive abilities Patients who can't read patients who don't speak french
Key Trial Info
Start Date :
January 21 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 20 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03822988
Start Date
January 21 2019
End Date
June 20 2019
Last Update
January 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy-Brabois hospital
Vandœuvre-lès-Nancy, France, 54500